Skip to main content
. 2023 Feb 3;24(3):2962. doi: 10.3390/ijms24032962

Figure 2.

Figure 2

Different modalities of canonical HH signaling activation in cancer cells: (a) type I ligand-independent; (b) type II ligand-dependent autocrine; (c) type IIIa ligand-dependent; (d) type IIIb ligand-dependent reverse paracrine. For details, see the text. HH, hedgehog ligand.